User login
Physicians with difficult patient scenarios regularly bring their questions to the AGA Community to seek advice from colleagues about therapy and disease management options, best practices, and diagnoses. Here’s a preview of a recent popular clinical discussion:
Vikrant Parihar, MD, wrote the following in “COVID-19 and UC”:
A 43-year-old man with an index presentation of distal colitis (Montreal E2) (Mayo endoscopic score 2-3) was discharged home on tapering doses of oral steroids. He was being worked up to commence anti-TNF likely initially as combo therapy. Fully vaccinated against COVID – had both doses of vaccine way back in May. Attended a match and looks to have got mild symptoms and on testing turned out to be COVID+. Rx himself by self-quarantine.
What would be the optimal strategy?
1. Stop steroids completely and immediately given the adverse signal in registry data?
2. When can anti-TNF’s be safely started?
3. How to manage him in the interim?
See how AGA members responded and join the discussion: https://community.gastro.org/posts/25172.
Physicians with difficult patient scenarios regularly bring their questions to the AGA Community to seek advice from colleagues about therapy and disease management options, best practices, and diagnoses. Here’s a preview of a recent popular clinical discussion:
Vikrant Parihar, MD, wrote the following in “COVID-19 and UC”:
A 43-year-old man with an index presentation of distal colitis (Montreal E2) (Mayo endoscopic score 2-3) was discharged home on tapering doses of oral steroids. He was being worked up to commence anti-TNF likely initially as combo therapy. Fully vaccinated against COVID – had both doses of vaccine way back in May. Attended a match and looks to have got mild symptoms and on testing turned out to be COVID+. Rx himself by self-quarantine.
What would be the optimal strategy?
1. Stop steroids completely and immediately given the adverse signal in registry data?
2. When can anti-TNF’s be safely started?
3. How to manage him in the interim?
See how AGA members responded and join the discussion: https://community.gastro.org/posts/25172.
Physicians with difficult patient scenarios regularly bring their questions to the AGA Community to seek advice from colleagues about therapy and disease management options, best practices, and diagnoses. Here’s a preview of a recent popular clinical discussion:
Vikrant Parihar, MD, wrote the following in “COVID-19 and UC”:
A 43-year-old man with an index presentation of distal colitis (Montreal E2) (Mayo endoscopic score 2-3) was discharged home on tapering doses of oral steroids. He was being worked up to commence anti-TNF likely initially as combo therapy. Fully vaccinated against COVID – had both doses of vaccine way back in May. Attended a match and looks to have got mild symptoms and on testing turned out to be COVID+. Rx himself by self-quarantine.
What would be the optimal strategy?
1. Stop steroids completely and immediately given the adverse signal in registry data?
2. When can anti-TNF’s be safely started?
3. How to manage him in the interim?
See how AGA members responded and join the discussion: https://community.gastro.org/posts/25172.